Consulter les CV

<< Liste des offres

consultante dossier de transparence
Catégorie :


Date de dernière mise à jour :

22 avril 2010

Lieu :

paris ile de france

CV :

Hélène Kolsky HEC : Master of Coaching
3, Clos de la Bergerie Doctor of Medecine
78240 Chambourcy High Management Position in Pharmaceutical Industry
Phone/Fax: 00 33 1 30 74 11 93
Mobile: 00 33 6 07 77 27 29

High Management Position in Pharmaceutical Industry

· Ability to manage and mentor multidisciplinary teams towards common objectives and results,
· Negotiation skills with high level of credibility,
· Ability to create and communicate clear vision based on internal and external variables,
· Strong verbal and written communication skills,
· Ability to create partnerships with all authorities.

Work experience

Since 2007 :
· Interim Manager : In Life Management for Adler Life Sciences (Business & Competitive intelligence)
· Consultant :
. UCB Pharma
. Astra-Zeneca
. Novartis
· IMS Healthcare (comprehensive market intelligence),
· JNB developement (Strategic Consultants in the Healthcare Industry),
· Scherring Plough,
· Ferring,
· The Medecine Compagny (transparency and economic fil preparation and submission nearby the French Health Authority),
· I.C.M.E : Strategy Alignment, Business Creation of the Health Pharma Domain.
· Coaching : Professional and personnal course.

2000 - 2007 : 3M Healthcare

Scientific & Institutional Affairs Manager (2004 - January 2007)
Manage 3 teams to create and maintain a synergy across medical, regulatory and health economic affairs for a better optimization of the cycle life of drugs.
· Match medical, regulatory and institutional plan with the French pharma business perspectives and cascade into high level tactical study,
· Increase the credibility of 3M Healthcare nearby the Health Authorities (HA),
· Optimize the relationship with the HA in order to gain the best position for negotiation.
· Re-negotiation of a 1M€ rebate per year (Economic Committee 2003, 2004),
· Global revaluation of a dossier at the Transparency Committee level (2005),
· Successful negotiation with Economic Committee : dramatic improvement of the agreement payback clause (2005).

Medical Manager MENA & North Africa (European position) (2002 - 2004)
· Seize a significant share of the growth potential in Eastern Europe and MENA with Aldara and Flecaine/Tambocor,
· Select where to prioritize investments by evaluating market potentials,
· Prioritize countries and cluster them by key attractiveness factors to generate entries and development options,
· Ensure the proper transformation of analyses into operational action plans.

Medical Manager (Cardiology, Dermatology, Immunology, Respiratory) (2000 - 2002)
· Define local strategies in liaise with accurate reglementary guidelines as well as business needs,
· Participate to the European strategy,
· Contribute to early developments,
· Manage board of key opinion leaders.
· Management of a clinical team (15 to 25 people) : clinical operations, project leaders, project managers, quality management, documentation & library, CRO management,
· Budget 3.2 M€,
· Member of the Management Committee and the European Medical Director Committee,
· Pricing & reimbursement dossier,
· French phase III & IV clinical trials and surveys (epidemiological and observational surveys),
· Pan European phase II & III clinical trials (new indication),
· Safety : benefit risk ratio-evaluation,
· Support marketing activities of 3M Pharma and occasionally medical advices,
· Support other affiliates.
· 3M Pharma France recognized as center of excellence by the headquarter,
· National MAA of flecaine CR through an hybrid dossier with a good ASMR rating leading to a successful price negotiation (higher price than that of the former formulation),
· Application of the French dossier to other EU countries thanks to a hearing nearby the local health authorities.

1992 - 1999 : BAYER PHARMA : Therapeutic Areas Manager (Cardiology, Metabolism, CNS)

Create a team spirit with 15 people (7 clinical project leaders).
· Built international development plans in relationship with headquarters, seek for validation by the French authorities (AFSSAPS),
· Perform international phase II & III clinical trials across Europe,
· Budget 50 000 kF.
· Certification ISO 9001 (October 1994) (1st medical department in the pharmaceutical industry),
· MAA : Nifédipine GITS (angina pectoris and hypertension),
Nisoldipine (hypertension),
Aspirine (secondary prevention),
Métrifonate (Alzheimer disease).

1979 - 1992 : HOECHST : Clinical Project Leader, then Cardiovascular Area Manager (5 physicians)

MAA: Cardiology : 1980 Molsidomine (Corvasal) 2 mg,
1984 Urokinase,
1987 Corvasal intracoronary infusion,
Corvasal 4 mg,
1990 Ramipril,
Endocrinology : 1985 Busereline (Suprefact) prostatic,
Gastroenterology : 1991 Roxatidine.


· French Society of Cardiology,
· French Society of Therapeutic and Clinical Pharmacology,
· AMIPs : Association of the Physicians belonging to the Pharmaceutical Industry (Vice president, 1997-2003).

Hospital activities

· Tenon hospital, Paris (1979-1982),
· Rothschild hospital, Paris (1976-1979).

Degree and training

· HEC coach diploma (2007) + PNL,
· Health economic environment (Sciences-Politiques, Paris 1993),
· Certified Clinical Pharmacology & Pharmacokinetic (1980),
· Certified cardiologist (1979),
· MD (1974) University of Paris V.

Foreign language

· English fluent,
· German spoken.

Ce CV vous intéresse ?
Vous pouvez lui laisser un message
*Nom :
Société :
Tél. :
*Votre email :
Cliquez sur l'image pour en afficher une nouvelle
*Entrez le texte de l'image
* denotes required field

Recevez nos offres d'emploi par e-mail